A randomized controlled trial evaluated the efficacy and safety of apixaban for prevention of recurrent thrombosis after thrombectomy of hemodialysis vascular access

Autor: Ko, Tsung-Yu, Wu, Chih-Cheng, Hsieh, Mu-Yang, Yang, Chung-Wei, Cheng, Chi-Hung, Chen, Chun-Kai, Kao, Hsien-Li
Zdroj: In Kidney International October 2024
Databáze: ScienceDirect